Improving future cancer treatments
By BARBARA HOLT | February 28, 2013When the life of a loved one is in jeopardy, there are almost no limits to what people will do or try in order to save them. When an unnamed friend of James Eshleman, Associate Director of Johns Hopkins Molecular Diagnostics Laboratory and researcher for the Departments of Oncology and Pathology, was stricken with an ultra-rare form of cancer, his friend’s uncle, who happened to be Vice President of a major pharmaceutical company, asked Eshleman to provide him with a personalized cell line on which he could test every drug his company owned. Eshleman willingly complied with the request to save his friend.